Macomics Ltd.
- Biotech or pharma, therapeutic R&D
A macrophage (inc microglia) targeting drug discovery company, developing modality agnostic therapeutics
Lead Asset is an IND ready for novel target antibdy for CRPC
June 16-19, 2025
Boston Convention & Exhibition Center
A macrophage (inc microglia) targeting drug discovery company, developing modality agnostic therapeutics
Lead Asset is an IND ready for novel target antibdy for CRPC